Lusutrombopag Interactions
There are 156 drugs known to interact with lusutrombopag, along with 2 disease interactions. Of the total drug interactions, 4 are major, and 152 are moderate.
- View lusutrombopag disease interactions (2)
Medications known to interact with lusutrombopag
Note: Showing generic names only.
- abiraterone
- abrocitinib
- acalabrutinib
- afatinib
- alpelisib
- amiodarone
- apremilast
- asciminib
- astemizole
- atazanavir
- avacopan
- azithromycin
- C1 esterase inhibitor (human)
- cabozantinib
- capmatinib
- carfilzomib
- carvedilol
- ceritinib
- clarithromycin
- cobicistat
- conestat alfa
- conivaptan
- cyclosporine
- elacestrant
- elagolix
- eliglustat
- eltrombopag
- enasidenib
- encorafenib
- entrectinib
- enzalutamide
- erythromycin
- etravirine
- ezogabine
- ibritumomab
- ibrutinib
- idelalisib
- isavuconazonium
- istradefylline
- itraconazole
- ivacaftor
- ivosidenib
- ixabepilone
- lapatinib
- lasmiditan
- lazertinib
- lenacapavir
- lenalidomide
- leniolisib
- levacetylleucine
- levoketoconazole
- lomitapide
- lovastatin
- pacritinib
- palbociclib
- pirtobrutinib
- pomalidomide
- ponatinib
- posaconazole
- pralsetinib
- pretomanid
- progesterone
- propafenone
- safinamide
- saquinavir
- sarecycline
- selpercatinib
- simeprevir
- simvastatin
- sonidegib
- sorafenib
- sotorasib
- sparsentan
- spironolactone
- suvorexant
- tacrolimus
- tafamidis
- tamoxifen
- tedizolid
- telaprevir
- telithromycin
- tepotinib
- terfenadine
- teriflunomide
- testosterone
- thalidomide
- ticagrelor
- tivozanib
- tolbutamide
- tolvaptan
- treosulfan
- trifluoperazine
- trimethoprim
- troleandomycin
- tucatinib
Lusutrombopag disease interactions
There are 2 disease interactions with lusutrombopag which include:
Report options
More about lusutrombopag
- lusutrombopag consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet-stimulating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Promacta
Promacta is used to prevent bleeding episodes in patients with chronic immune (idiopathic) ...
Rayos
Rayos (prednisone, delayed-release) is used to treat rheumatoid arthritis, polymyalgia rheumatica ...
Nplate
Nplate is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura ...
Eltrombopag
Eltrombopag systemic is used for aplastic anemia, immune thrombocytopenia, thrombocytopenia ...
Rituximab
Rituximab infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Dexamethasone
Dexamethasone is used to treat inflammatory conditions such as allergies, skin conditions ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
